Studies have confirmed that in the context of diabetes, various pathogenic stimuli, including hyperglycemia and the accumulation of advanced glycation end products (AGEs), can induce renal parenchymal cells to undergo cellular senescence (Liu et al., 2015
One in eight US adults have already taken GLP-1 drugs for weight loss or blood sugar control, and the figure is predicted to rise to up to one in six in the future
Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
Vapourtec is perfectly placed to support scientists who are looking to transition over to CF- SPPS applications, added Manuel
With 8 grams of fiber and just 2 net carbs, No Worries supports weight loss, bone and muscle recovery, and gut health